I mistakenly posted the response below to a psea post

New Post Public Reply Private Reply Replies (0) Message Board
ClosetInvestor misiu143 #26406
481
I mistakenly posted the response below to a psea post earlier this morning. I’m not sure how that happened, but the message was meant for misiu143, a response to her post #26406 from her yesterday. My apologies psea.

“It look that some group of people absolutely can’t accept that this treatment (hydroxychloroquine) is working with many, especially when started soon...”

You’re a self proclaimed doctor, who has also claimed to have participated in administering clinical trial medications to patients, and you’re asking why investors and health care professionals wont accept a clinically unproven drug for COVID? That’s absurd. You, of anyone, should understand how the FDA works in regards to approving drugs for certain indications. Yes, doctors talk amongst themselves and share preliminary results, but that talk is not meant for the general population and isn’t considered FACTs until proven by an official study. Dr. Fauci, the CDC, and the FDA are treating hydroxychloroquine like every other potential COVID treatment until a study shows efficacy: an unproven drug for the indication. And, of any drug for COVID patients, hydroxychloroquine needs further research because of the trials from China and around the world that have shown very different results.

“We all know why I believe ...”

I’m not sure what answer is possible because you personally aren’t prescribing the medication to COVID patIents and there isn’t an FDA approved trial showing efficacy. There is only anecdotal data that varies widely in efficacy.

Media and social media platforms are dangerous with disinformation in regards to COVID19 and treatments. I came across a video from a “Dr.” yesterday on social media that was discussing preventions and treatment for COVID19. This video had over 100K views. The “Dr.” was discussing notes he’d gotten from another Dr at an urgent care that showed promising results with early anti-biotic treatment. This “Dr.” then started discussing alternative treatments and prevention, including drinking tonic water everyday to prevent one from contracting COVID. After a little research, I discovered this “Dr.” is actually a chiropractor and is the owner of a wellness center. He didn’t mention this In the video, but from the comments, people were widely supporting his unsupported claims.

This is dangerous and people on social media are making similar videos and claims about hydroxychloroquine. I want to keep this non-political and consider myself in the middle on politics (more apolitical than anything), but I’d like to point out that the majority of individuals really pushing hydroxychloroquine are conservative and have ZERO medical knowledge. Like why’s, those who really bash the medication tend to be liberals. The topic of hydroxychloroquine and COVID should’ve never become political and should’ve been left to doctors and researchers, but unfortunately like every aspect of life today, politicians politicize everything for personal and political gain.
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phoenix Contact Achieves Guinness Record in Wiring

Updated Category News Views 103

A Blitz of Wires and Innovation Boy, did Phoenix Contact shake things up in Blomberg. On a crisp November day, a group of fresh-faced first-year students pulled off something astounding—wiring 500 terminal blocks in a jaw-dropping 2 minutes and 20 seconds. This wasn’t just any effort; it was enough to earn them a shiny new Guinness World Record. What they did wasn’t...

Continue Reading
Pony.ai & Toyota Launch 1,000 Gen-7 Robotaxis in China

Updated Category News Views 110

Revving Up the Autonomous Ride Revolution Not every day you see two giants, Pony.ai and Toyota, join forces to shake up the way folks get from A to B. But here we are — they’ve fired up their engines in Guangzhou, unleashing their Gen-7 bZ4X Robotaxis for commercial use. And let me tell you, this is no shot in the dark. With plans to dot about 1,000 of these...

Continue Reading
Sasol AGM Resolutions Passed in One Swift Swing

Updated Category News Views 39

Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 95

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 142

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 10

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 423

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 43

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 52

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 53

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading

Top 5 Most Recently Viewed Articles

STMicroelectronics Unveils Latest Financial Performance Insights

Updated Category News Views 215

Overview of STMicroelectronics’ Third Quarter Results STMicroelectronics N.V. (“ST”) (NYSE: STM), a prominent figure in the semiconductor sector, announced its financial results for the third quarter, showcasing a robust revenue of $3.25 billion. This figure represents a gross margin of 37.8% and an operating margin of 11.7%, culminating in a net income of $351...

Continue Reading
Celebrating the Unique Career Opportunities at McDonald's

Updated Category News Views 654

Explore the Benefits of Working at McDonald's Finding a meaningful job can be tough, but for many, McDonald's is more than just a fast-food place. It's a stepping stone for personal and professional development. Numerous individuals have experienced major career growth thanks to their time at McDonald's, reflecting the company’s dedication to helping its employees...

Continue Reading
Key Insights on New Fortress Energy Class Action & Legal Help

Updated Category News Views 153

Understanding the New Fortress Energy Class Action Investors in New Fortress Energy Inc. (NASDAQ: NFE) should be cognizant of legal developments surrounding their investments. This class action lawsuit emerges from concerns that misrepresentations regarding the company's revenue and growth forecasts misled investors during a designated class period. Important Details...

Continue Reading
Mauna Kea Technologies Reports Promising IBS Findings with Cellvizio

Updated Category News Views 58

Mauna Kea Technologies Presents Clinical Advances for Cellvizio in IBS Mauna Kea Technologies (Euronext Growth: ALMKT), the innovative creator of Cellvizio, recently unveiled new clinical insights regarding its advanced laser endomicroscopy system. This technology showcases potential in diagnosing and managing food intolerances, specifically focusing on individuals...

Continue Reading
Resilience in Asia's Stock Markets Amid Mixed Signals

Updated Category News Views 72

Resilience in Asia's Stock Markets Amid Mixed Signals Most Asian stocks showed little movement on a recent Friday, characterized by uncertainty regarding U.S. interest rates and the approaching presidential election. However, the situation was different for Chinese shares, which turned positive following data that revealed growth in the economy, meeting investor...

Continue Reading